Poolbeg Pharma moves forward with oral vaccine programme

Poolbeg Pharma, a clinical-stage biopharma company focusing on infectious and other prevalent diseases with high unmet medical needs, has announced an update to its oral vaccine programme.

Related Keywords

Ireland ,Irish ,Jeremy Skillington ,Encovac Consortium ,Mcclean At University College Dublin ,Irish Government Disruptive Technologies Innovation Fund ,School Of Biomolecular ,Professor Ed Lavelle At Trinity College Dublin ,Irish Government ,Disruptive Technologies Innovation Fund ,Anabio Technologies ,Associate Professor Siobh ,University College Dublin ,Professor Ed Lavelle ,Trinity College ,Professor Siobh ,Biomedical Science ,Bio Developments ,Emerging Markets ,Vaccine ,Infectious Disease ,Immune System ,